COMMUNIQUÉS West-GlobeNewswire

-
FDA Provides Guidance on Clinical Pathway to Marketing Application for Revascor in End-Stage Heart Failure Patients With an LVAD
27/08/2019 -
New Data From Aslan’s Study of Varlitinib in China Accepted as Late-Breaking Oral Presentation at 2019 CSCO Annual Meeting
27/08/2019 -
The Alliance for Regenerative Medicine Releases Statement of Principles on Genome Editing
27/08/2019 -
Zealand Pharma relocates headquarters to accommodate growth
27/08/2019 -
The Management Board of JSC Olainfarm prevents fraudulent use of the company's assets
27/08/2019 -
Basilea announces completion of patient enrolment in phase 1 study with oral BAL101553 in brain cancer
27/08/2019 -
Press release Biocartis NV: Invitation to the Special Shareholders’ Meeting
27/08/2019 -
Van Leeuwenhoeck Issues Equity Research Report with Strong Buy and Price Target of CHF11-12 per Share
27/08/2019 -
Santhera Announces Publication by ReveraGen of Positive Phase IIa-Extension Study Results with Vamorolone in Patients with Duchenne Muscular Dystrophy
27/08/2019 -
National Research Corporation Declares Quarterly Dividend
26/08/2019 -
Iovance Biotherapeutics to Present at Upcoming Investor Conferences in September
26/08/2019 -
STERIS to Participate in the Morgan Stanley Global Healthcare Conference
26/08/2019 -
Wave Life Sciences to Present at the Morgan Stanley Global Healthcare Conference
26/08/2019 -
Nuvectra® Exploring Strategic Options to Enhance Shareholder Value
26/08/2019 -
SI-BONE to Present at the 17th Annual Morgan Stanley Global Healthcare Conference on September 10, 2019
26/08/2019 -
TransMedics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference
26/08/2019 -
Paratek Pharmaceuticals to Present at Robert W. Baird’s 2019 Global Healthcare Conference
26/08/2019 -
Atreca Announces Appointment of Dr. Lindsey Rolfe to its Board of Directors
26/08/2019 -
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
26/08/2019
Pages